Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Effectiveness of egg yolk antibody against shiga toxin II variant toxicity in vitro and in vivo.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • المؤلفون: Feng Y;Feng Y; Liu W; Shi D
  • المصدر:
    Current microbiology [Curr Microbiol] 2013 Oct; Vol. 67 (4), pp. 448-53. Date of Electronic Publication: 2013 May 21.
  • نوع النشر :
    Journal Article; Research Support, Non-U.S. Gov't
  • اللغة:
    English
  • معلومة اضافية
    • المصدر:
      Publisher: Springer International Country of Publication: United States NLM ID: 7808448 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1432-0991 (Electronic) Linking ISSN: 03438651 NLM ISO Abbreviation: Curr Microbiol Subsets: MEDLINE
    • بيانات النشر:
      Original Publication: New York, Springer International.
    • الموضوع:
    • نبذة مختصرة :
      We prepared anti-Shiga toxin II variant (Stx2e) and anti-Stx2e B antibodies in chicken egg yolk and investigated their effectiveness in vitro and in vivo. Both Egg yolk antibodies (IgY) reduced the cytotoxic effects of Stx2e to Vero cells. The protective efficacy of anti-Stx2e IgY and anti-Stx2e B IgY was investigated in clean Kunming mice, which were experimentally induced with Stx2e. Peritoneal injection of anti-Stx2e IgY and anti-Stx2e B IgY apparently reduced the lethal effect of Stx2e to mice. These results indicate that both anti-Stx2e IgY and anti-Stx2e B IgY could protect mice from Stx2e challenge. Therefore, anti-Stx2e IgY or anti-Stx2e B IgY might be considered as potential candidate for therapeutics for porcine edema disease.
    • References:
      Vet Microbiol. 1991 Nov;29(3-4):309-18. (PMID: 1837635)
      Helicobacter. 2005 Feb;10(1):43-52. (PMID: 15691314)
      Vet Microbiol. 1993 Oct;37(1-2):135-46. (PMID: 8296443)
      Infect Immun. 2012 Jan;80(1):469-73. (PMID: 22083704)
      Infect Immun. 1990 May;58(5):1232-9. (PMID: 2182539)
      Can J Vet Res. 2006 Jan;70(1):62-4. (PMID: 16548334)
      Biosci Biotechnol Biochem. 2009 Jul;73(7):1628-34. (PMID: 19584542)
      Infect Immun. 1992 Mar;60(3):998-1007. (PMID: 1347289)
      PLoS One. 2011;6(10):e26526. (PMID: 22028896)
      J Clin Microbiol. 2006 Sep;44(9):3074-7. (PMID: 16954229)
      Toxicon. 2011 Sep 15;58(4):380-8. (PMID: 21803069)
      Vet Microbiol. 1999 Feb 23;65(1):37-45. (PMID: 10068126)
      Infect Immun. 2003 Sep;71(9):5194-201. (PMID: 12933864)
      Vaccine. 1998 Feb;16(4):388-93. (PMID: 9607060)
      J Sci Food Agric. 2011 Aug 30;91(11):1946-50. (PMID: 21495036)
      Infect Immun. 1992 Feb;60(2):485-90. (PMID: 1730480)
      Toxicon. 2008 Aug 1;52(2):221-7. (PMID: 18590753)
      J Oral Sci. 2007 Sep;49(3):201-6. (PMID: 17928726)
      J Vet Med Sci. 1997 Oct;59(10):917-21. (PMID: 9362041)
      J Med Food. 2002 Fall;5(3):159-69. (PMID: 12495588)
      Oral Microbiol Immunol. 2007 Oct;22(5):352-5. (PMID: 17803634)
      J Biol Chem. 1989 Jul 25;264(21):12520-5. (PMID: 2663859)
      Trop Anim Health Prod. 2010 Dec;42(8):1797-804. (PMID: 20661643)
      Vet Microbiol. 1997 Mar;54(3-4):329-41. (PMID: 9100333)
    • الرقم المعرف:
      0 (Antibodies)
      0 (Antibodies, Bacterial)
      0 (Shiga Toxin 2)
    • الموضوع:
      Date Created: 20130522 Date Completed: 20140224 Latest Revision: 20211021
    • الموضوع:
      20250114
    • الرقم المعرف:
      10.1007/s00284-013-0384-8
    • الرقم المعرف:
      23689941